AMGN analyst estimates

Amgen (AMGN) analyst ratings, the average price target and its range, and every firm's latest call.

AMGN analyst ratings and price targets

DateFirmCallTarget
Nov 12, 2026Argus ResearchAmgen (AMGN) PT Raised to $515 at Argus$515.00
Nov 6, 2026Freedom BrokerFreedom Broker Downgrades Amgen (AMGN) to Hold$470.00
Nov 4, 2026Wells FargoAmgen (AMGN) PT Raised to $460 at Wells Fargo$460.00
Nov 4, 2026Canaccord GenuityAmgen (AMGN) PT Raised to $440 at Canaccord$440.00
Nov 4, 2026Truist FinancialAmgen (AMGN) PT Raised to $398 at Truist Securities$398.00
Nov 4, 2026RBC CapitalAmgen (AMGN) PT Raised to $470 at RBC Capital$470.00
Nov 4, 2026BernsteinAmgen (AMGN) PT Raised to $400 at Bernstein SocGen Group$400.00
Nov 4, 2026TD CowenAmgen (AMGN) PT Raised to $531 at TD Cowen$531.00
Nov 4, 2026Cantor FitzgeraldAmgen (AMGN) PT Raised to $465 at Cantor Fitzgerald$465.00
Oct 23, 2026OppenheimerAmgen (AMGN) PT Raised to $480 at OppenheimerMember Login$480.00
Oct 21, 2026BarclaysAmgen price target raised to $400 from $380 at Barclays$400.00
Oct 13, 2026GuggenheimAmgen price target lowered to $378 from $388 at Guggenheim$378.00
Oct 12, 2026Wells FargoAmgen price target lowered to $430 from $435 at Wells Fargo$430.00
Oct 12, 2026BMO CapitalAmgen price target lowered to $415 from $450 at BMO Capital$415.00
Oct 8, 2026RBC CapitalAmgen price target raised to $430 from $400 at RBC Capital$430.00